- Todos > Medicine Access and Rational Use > Rational Use
- Todos > Medicine Access and Rational Use > Selection
- Palabras clave > classification of drugs and poisons
- Palabras clave > criteria of medicines selection
- Palabras clave > Hospital Pharmacy and Therapeutics Committees (HPTC) / Hospital Medicine and Therapeutics Committees (HMTC)
- Palabras clave > MeTA - The Medicines Transparency Alliance
- Palabras clave > Pharmacy and Therapeutics Committee - PTC
- Palabras clave > rational use of medicines (RUM) / rational medicine use (RMU)
- Palabras clave > selection of medicines
- Palabras clave > transparency
(2014; 48 pages)
Jordan, like all countries, is faced with a difficult problem; how to provide equitable, evidence-based and cost-effective health care within the capacity of a country's ability to pay. Health expenditure accounted for 7.7% of the GDP and 27% of this spending was on medicines, of which 45% of this spending occurs in the public sector. Because of this, rational use of medicines in health care become a pressing issue as Jordan has the challenge of balancing its scarce resources on one hand and providing equitable quality healthcare to its growing population on the other.
Different studies conducted in Jordan emphasized that the problem with rational use of medicines , these problems include poor organization and management of health services at all levels; weakness of the health information system and lack of access to an update unbiased information on the currently used drugs; poor communication between health professional & patient; promotional activities of pharmaceutical industries; over prescribing of antimicrobials; self-medication by the public of prescription drugs, including inappropriate use of antibiotics; poor compliance; lack of patient education about illnesses & drugs; inadequate training & education of medical graduates in good prescribing practice; lack of continuing medical education for doctors & pharmacists, and lack of standard treatment guidelines.
The rational use of medicine strategy in Jordan is highly fragmented. According to legislation, the Rational Drug Use Department within the JFDA is the coordinating entity for activities surrounding the rational use of medicine, including the development of standard treatment guidelines and the updating of the Jordan Rational Drug List and Jordan National Drug Formulary. The rational drug use policy is not fully implemented.